Express Scripts, officially known as Express Scripts Holding Company, is a leading pharmacy benefit management (PBM) organisation headquartered in the United States. Founded in 1986, the company has established itself as a key player in the healthcare industry, primarily serving clients across North America. With a focus on optimising prescription drug benefits, Express Scripts offers a range of services, including formulary management, medication adherence programmes, and specialty pharmacy solutions. Their innovative approach to managing pharmacy benefits has positioned them as a trusted partner for employers, health plans, and government entities. Notable achievements include their commitment to improving patient outcomes and reducing healthcare costs, making them a prominent force in the PBM sector. Through their comprehensive services, Express Scripts continues to enhance the accessibility and affordability of medications for millions of individuals.
How does Express Scripts's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Express Scripts's score of 46 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Express Scripts, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The organisation is a current subsidiary of The Cigna Group, which influences its climate commitments and targets. As part of its corporate family, Express Scripts inherits sustainability initiatives and targets from The Cigna Group, including those related to the Science Based Targets initiative (SBTi) and the RE100 commitment. However, specific reduction targets or achievements for Express Scripts itself have not been disclosed. The absence of detailed emissions data suggests that Express Scripts is still in the process of establishing its own climate strategy, while aligning with the broader sustainability goals set by its parent company. This context highlights the importance of corporate responsibility in the healthcare sector, particularly in addressing climate change and reducing carbon footprints.
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 11,737,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - |
| Scope 2 | 75,874,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 00,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - |
| Scope 3 | 25,072,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000,000 | 000,000 |
Express Scripts's Scope 3 emissions, which decreased by 100% last year and decreased by approximately 98% since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Employee Commuting" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Express Scripts has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.